{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:35:13Z","timestamp":1791477313128,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clinbiochem.2024.110792","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T22:59:35Z","timestamp":1720565975000},"page":"110792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Canadian guidance for diagnosis and management of acute hepatic porphyrias"],"prefix":"10.1016","volume":"131-132","author":[{"given":"Juan","family":"Francisco Idiaquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam A.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Thoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sholzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Colantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5805-4883","authenticated-orcid":false,"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2024.110792_b0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.gastro.2019.04.050","article-title":"Clinical Guide and Update on Porphyrias","volume":"157","author":"St\u00f6lzel","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0010","doi-asserted-by":"crossref","unstructured":"V.-M.S. Ramanujam, K.E. Anderson, Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias, Curr. Protoc. Hum. Genet. 86 (2015) 17.20.1\u201317.20.26. Doi: 10.1002\/0471142905.hg1720s86.","DOI":"10.1002\/0471142905.hg1720s86"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jemermed.2015.04.034","article-title":"Acute Porphyrias","volume":"49","author":"Besur","year":"2015","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14218\/JCTH.2014.00039","article-title":"Acute Hepatic Porphyria","volume":"3","author":"Bissell","year":"2015","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/joim.12750","article-title":"Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver","volume":"284","author":"Schmitt","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/humu.23067","article-title":"Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease","volume":"37","author":"Chen","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0040","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/hep.30936","article-title":"EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks","volume":"71","author":"Gouya","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/003655100300054891","article-title":"The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study","volume":"60","author":"Andersson","year":"2000","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0050","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0055","unstructured":"K.E. Anderson, S. Sassa, D.F. Bishop, R.J. Desnick, Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias, in: McGraw Hill Medical, n.d. https:\/\/ommbid.mhmedical.com\/content.aspx?bookId=2709&sectionId=225540906 (accessed August 14, 2023)."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0060","doi-asserted-by":"crossref","first-page":"E4071","DOI":"10.1073\/pnas.1719267115","article-title":"Human hydroxymethylbilane synthase: Molecular dynamics of the pyrrole chain elongation identifies step-specific residues that cause AIP","volume":"115","author":"Bung","year":"2018","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0065","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ymgme.2018.11.012","article-title":"Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying\/causative genes","volume":"128","author":"Yasuda","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0070","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0075","series-title":"Acute Intermittent Porphyria","author":"Whatley","year":"2019"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hep4.1297","article-title":"Acute Hepatic Porphyrias: Review and Recent Progress","volume":"3","author":"Wang","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10545-010-9142-2","article-title":"A retrospective analysis of outcome of pregnancy in patients with acute porphyria","volume":"33","author":"Marsden","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2796.2010.02335.x","article-title":"Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden","volume":"269","author":"Innala","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0095","doi-asserted-by":"crossref","unstructured":"K. Peoc\u2019h, H. Manceau, Z. Karim, S. Wahlin, L. Gouya, H. Puy, J.-C. Deybach, Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword, Mol. Genet. Metab. 128 (2019) 236\u2013241. Doi: 10.1016\/j.ymgme.2018.10.001.","DOI":"10.1016\/j.ymgme.2018.10.001"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0100","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.2016080918","article-title":"A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease","volume":"28","author":"Tchernitchko","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0004563216667965","article-title":"Best practice guidelines on first-line laboratory testing for porphyria","volume":"54","author":"Woolf","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0110","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/s41436-019-0537-7","article-title":"International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias","volume":"21","author":"Chen","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0115","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1373\/clinchem.2008.122564","article-title":"Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene","volume":"55","author":"Whatley","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/TACG.S48605","article-title":"An update of clinical management of acute intermittent porphyria","volume":"8","author":"Pischik","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.gastro.2022.11.034","article-title":"AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.920668","article-title":"An Extended C-Terminus, the Possible Culprit for Differential Regulation of 5-Aminolevulinate Synthase Isoforms","volume":"9","author":"Hunter","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0135","doi-asserted-by":"crossref","first-page":"20516","DOI":"10.1074\/jbc.M116.719161","article-title":"Novel Mechanisms for Heme-dependent Degradation of ALAS1 Protein as a Component of Negative Feedback Regulation of Heme Biosynthesis","volume":"291","author":"Kubota","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107670","article-title":"Acute hepatic porphyrias: Recommendations for diagnosis and management with real-world examples","volume":"140","author":"Moghe","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/8904_2015_458","article-title":"Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series","volume":"25","author":"Willandt","year":"2016","journal-title":"JIMD Rep."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood.V61.2.243.243","article-title":"Hematin: unique effects of hemostasis","volume":"61","author":"Glueck","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0155","first-page":"1050","article-title":"Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools","volume":"86","author":"Bonkovsky","year":"1991","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/0003-4819-144-7-200604040-00023","article-title":"Reconstitution of hematin for intravenous infusion","volume":"144","author":"Anderson","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0165","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.322.7297.1297","article-title":"Measuring quality of life: Using quality of life measures in the clinical setting","volume":"322","author":"Higginson","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0170","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2019.07.002","article-title":"Acute hepatic porphyrias: Current diagnosis & management","volume":"128","author":"Anderson","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0026-0495(64)90103-9","article-title":"I. THE EFFECT OF DIET","volume":"13","author":"Welland","year":"1964","journal-title":"Metabolism"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0190","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/jimd.12551","article-title":"EXPLORE B: A prospective, long-term natural history study of patients with acute hepatic porphyria with chronic symptoms","volume":"45","author":"Cassiman","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF03008790","article-title":"Acute intermittent porphyria and caesarean delivery","volume":"39","author":"Kantor","year":"1992","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0200","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jimd.12616","article-title":"Maternal and fetal outcomes in acute hepatic porphyria: A Swedish National Cohort Study","volume":"46","author":"Mantel","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10545-010-9231-2","article-title":"Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study","volume":"34","author":"Toll\u00e5nes","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0210","first-page":"5554","article-title":"Treatment of acute intermittent porphyria during pregnancy and posterior reversible encephalopathy syndrome after delivery: A case report","volume":"14","author":"Zhang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/joim.13376","article-title":"Acute hepatic porphyria and maternal health: Clinical and biochemical follow-up of 44 pregnancies","volume":"291","author":"Vassiliou","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0220","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1468-1331.2006.01238.x","article-title":"Treatment of an acute attack of porphyria during pregnancy","volume":"13","author":"Badminton","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bjae.2020.09.005","article-title":"Acute hepatic porphyria and anaesthesia: a practical approach to the prevention and management of acute neurovisceral attacks","volume":"21","author":"Wilson-Baig","year":"2021","journal-title":"BJA Educ"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2796.1996.21847000.x","article-title":"The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria","volume":"240","author":"Andersson","year":"1996","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/8904_2015_406","article-title":"Occurrence of Malignant Tumours in the Acute Hepatic Porphyrias","volume":"22","author":"Lang","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.0954-6820.1984.tb05005.x","article-title":"Hepatocellular carcinoma in patients with acute intermittent porphyria","volume":"215","author":"Lithner","year":"1984","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0245","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/joim.13463","article-title":"Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals","volume":"291","author":"Lissing","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0250","unstructured":"Upcoming guidelines, (n.d.). https:\/\/canadiantaskforce.ca\/guidelines\/upcoming-guidelines\/ (accessed April 23, 2024)."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2796.1994.tb01279.x","article-title":"Hypertension and renal disease in patients with acute intermittent porphyria","volume":"236","author":"Andersson","year":"1994","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0260","first-page":"986","article-title":"Hypertension and renal impairment as complications of acute porphyria","volume":"7","author":"Church","year":"1992","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0265","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ki.2015.97","article-title":"High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria","volume":"88","author":"Pallet","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0270","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/jclinpath-2012-200791","article-title":"Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up","volume":"65","author":"Stewart","year":"2012","journal-title":"J. Clin. Pathol."},{"issue":"2020","key":"10.1016\/j.clinbiochem.2024.110792_b0275","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children","volume":"36","author":"Rabi","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0280","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(04)15646-8","article-title":"Liver transplantation as a cure for acute intermittent porphyria","volume":"363","author":"Soonawalla","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0285","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1432-2277.2009.01035.x","article-title":"Combined liver and kidney transplantation in acute intermittent porphyria","volume":"23","author":"Wahlin","year":"2010","journal-title":"Transpl. Int."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0290","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2119\/molmed.2015.00099","article-title":"Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver","volume":"21","author":"Yasuda","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0295","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/lt.25959","article-title":"European Liver and Intestine Transplant Association, Liver Transplantation for Acute Intermittent Porphyria","volume":"27","author":"Lissing","year":"2021","journal-title":"Liver Transpl."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0300","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/lt.21261","article-title":"Liver transplantation for porphyria: who, when, and how?","volume":"13","author":"Seth","year":"2007","journal-title":"Liver Transpl."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0305","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.27086","article-title":"Liver transplantation in the management of porphyria","volume":"60","author":"Singal","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0310","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2147\/DDDT.S281631","article-title":"Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy","volume":"16","author":"Majeed","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0315","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","article-title":"ENVISION Investigators, Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria","volume":"382","author":"Balwani","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0320","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-022-02314-9","article-title":"Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives","volume":"17","author":"Marcacci","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0325","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.29313","article-title":"Porphyrias Consortium of the Rare Diseases Clinical Research Network, Acute hepatic porphyrias: Recommendations for evaluation and long-term management","volume":"66","author":"Balwani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0330","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13023-021-01816-2","article-title":"Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study","volume":"16","author":"Gill","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0335","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jmd2.12343","article-title":"Quantifying the impact of symptomatic acute hepatic porphyria on well-being via patient-reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study","volume":"64","author":"Dickey","year":"2023","journal-title":"JIMD Rep."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0340","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40271-018-0319-3","article-title":"Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations","volume":"11","author":"Simon","year":"2018","journal-title":"Patient"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0345","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0004563212474555","article-title":"British and Irish Porphyria Network, Best practice guidelines on clinical management of acute attacks of porphyria and their complications","volume":"50","author":"Stein","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0350","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"APRICOT Clinical Investigators, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2024.110792_b0355","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/bjh.15166","article-title":"British Society for Haematology, Investigation and management of a raised serum ferritin","volume":"181","author":"Cullis","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clinbiochem.2024.110792_b0360","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"2010 clincal practice guidelines for the diagnosis and management of osteroporosis in Canada: summary","volume":"182","author":"Papaioannou","year":"2010","journal-title":"CMAJ"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:10:23Z","timestamp":1725916223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":72,"alternative-id":["S0009912024000869"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110792","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian guidance for diagnosis and management of acute hepatic porphyrias","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110792"}}